A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB. (2021)

First Author: Tweed CD

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5588/ijtld.20.0513

PubMed Identifier: 33762075

Publication URI: http://europepmc.org/abstract/MED/33762075

Type: Journal Article/Review

Volume: 25

Parent Publication: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Issue: 4

ISSN: 1027-3719